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Abstract
Background Intraoperative stimulation mapping (ISM) using electrocortical mapping (awake craniotomy, AC) or evoked po-
tentials has become a solid option for the resection of supratentorial low-grade gliomas in eloquent areas, but not as much for
high-grade gliomas. This meta-analysis aims to determine whether the surgeon, when using ISM and AC, is able to achieve
improved overall survival and decreased neurological morbidity in patients with high-grade glioma as compared to resection
under general anesthesia (GA).
Methods A systematic search was performed to identify relevant studies. Adult patients were included who had undergone
craniotomy for high-grade glioma (WHO grade III or IV) using ISM (among which AC) or GA. Primary outcomes were rate of
postoperative complications, overall postoperative survival, and percentage of gross total resections (GTR). Secondary outcomes
were extent of resection and percentage of eloquent areas.
Results Review of 2049 articles led to the inclusion of 53 studies in the analysis, including 9102 patients. The overall postop-
erative median survival in the AC group was significantly longer (16.87 versus 12.04 months; p < 0.001) and the postoperative
complication rate was significantly lower (0.13 versus 0.21; p < 0.001). Mean percentage of GTR was significantly higher in the
ISM group (79.1% versus 47.7%, p < 0.0001). Extent of resection and preoperative patient KPS were indicated as prognostic
factors, whereas patient KPS and involvement of eloquent areas were identified as predictive factors.
Conclusions These findings suggest that surgeons using ISM and AC during their resections of high-grade glioma in eloquent
areas experienced better surgical outcomes: a significantly longer overall postoperative survival, a lower rate of postoperative
complications, and a higher percentage of GTR.
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Introduction
Glioblastomas (WHO IV glioma) are devastating tumors
with one of the worst prognoses in oncology. The median
survival after surgery and combined treatment with
chemo- and radiotherapy ranges from 12 to 15 months
and no curative therapy is currently available [8, 23].
Multiple studies show that extent of resection of the con-
trast enhancing part of the tumor improves survival in
patients with GBM [15–18, 20–22, 24]. Further analyses
showed that patients who previously had complete resec-
tions derived the most benefit from the temozolomide
(TMZ) regimen compared with those who had had in-
complete resection [1]. Thus, in addition to the survival
benefit associated with maximum cytoreductive surgery,
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such surgery seems essential for the efficacy of modern
adjuvant treatment. More than 50% of GBMs are located
near or in eloquent areas of the brain. Damaging these
areas during surgery can lead to severe and permanent
neurological deficits that seriously impact the quality of
life. Therefore, when resecting GBMs in these areas, they
are usually not operated as aggressive as possible, due to
the chance of seriously damaging the patient with a rather
low life expectancy [13, 15–18, 20, 23]. However, pa-
tients with partial or subtotal resections will benefit less
from radio- and chemotherapy as compared to patients
with total resections [15–18, 20–22, 24].Intraoperative
stimulation mapping (ISM) allows the surgeon to prevent
damage to eloquent cortical and subcortical areas during
resection [2, 19]. There is compelling evidence that sur-
geons using ISM experience increased resection percent-
age while preserving quality of life in low-grade glioma
(LGG). We expect that the use of awake craniotomy by
surgeons therefore is also of important value in the sur-
gery of GBM, and in a similar fashion can optimize the
extent of resection and preserve quality of life, thereby
improving survival in these patients [2, 5–7, 9–12, 14,
19].
The usefullness of ISM by surgeons and its impact on neu-
rologic outcome has been evaluated mainly for mostly low-
grade gliomas or as a descriptive review. In this article, a meta-
analysis is performed to compare the surgeon’s use of intra-
operative stimulation mapping (among which awake craniot-




A computer-aided search of Embase, Medline (OvidSP), Web
of Science, the Cochrane Library, Pubmed, and Google
Scholar was performed to identify relevant studies. The search
terms used were (craniotomy OR surgery OR surgical ap-
proach OR surgical patient OR surgical technique OR brain
surgery OR brain tumor OR cancer surgery OR neurosurgery
OR intraoperative period) AND (wakefulness OR sedation
OR conscious sedation OR consciousness OR arousal OR
loca l anes thes ia OR loca l anes the t ic agen t OR
electrostimulation OR sensorimotor function OR (stimulation
AND brain cortex)) AND (glioma OR brain tumor OR brain
cancer OR intracranial tumor OR gliobastoma OR ((brain OR
intracranial OR supratentorial OR cortex OR cortical) NEAR
(tumor OR tumour OR cancer OR lesion)) NOT (conference
abstract OR letter OR note OR editorial) AND (english). The
publication period was restricted to January 1, 1990, to April
1, 2017. One reviewer (JKWG) performed the initial search in
association with a biomedical information specialist of the
library service of Erasmus Medical Centre, who verified the
search. Reference lists of the studies were searched for addi-
tional valuable studies.
Study selection criteria
To be included in the meta-analysis, all studies had to have
examined the effects of resective glioma surgery with or with-
out the use of ISM by surgeons. Studies were reviewed that
used resective glioma surgery to improve the prognosis in
patients with high-grade glioma (WHO III-IV). Only
complemented studies meeting the PICO format of this study
where full-text versions were available were included. PICO
(Population Intervention Comparison Outcome) restrictions
were made for population (patients under 18 years old were
excluded), intervention (fMRI, DTI, MSI, neuronavigation, or
ultrasound were not considered ISM), and outcome: eligible
primary outcomes were survival, extent of resection (percent-
age gross total resection—GTR), and complication rate.
Studies were exluded if they included patients with glioma
grading other thanWHO grade 3 or 4; patients under 18 years
old; when the pathohistology of the tumors was not specified;
when the article was of review-, editorial-, commentary-, short
report-format or was a chapter in a book; and when no abstract
was available (Fig. 1, flowchart).
Outcome measures and definitions
The primary outcome measures were the event rate of postop-
erative complications, overall survival, and percentage GTR.
Postoperative complications were noted as such as defined by
colleagues de Witt Hamer et al. [7] Complications were not
categorized according to severity and timing of assessment.
Complications were eligible as such when they emerged post-
operatively; when pre-operative symptoms worsened; or when
they were part of a worsening of the patients’ condition post-
operatively. The percentage of patients in whom GTR was
obtained according to postoperative neuroimaging was also
extracted. Furthermore, data regarding patient KPS and the
percentage of craniotomies concerning eloquent areas was col-
lected. Sources related to publication, population, or manage-
ment characteristics were distinguished. Publication-related
characteristics were publication year, continent, and study set-
ting. Patient population-related characteristics were mean age
and percentage of eloquently located gliomas. Treatment-
related characteristics were intraoperative techniques and sort
of anesthesia (awake or general anesthesia). Intraoperative
techniques included percentage of patients with resections
using ISM. For ISM, electrocortical mappingwas distinguished
from motor- or somatosensory evoked potentials (MEP, SEP).
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Statistical analysis
Differences between the ISM group (with or without AC) and
GA group for the primary outcomes were tested: (1) overall
postoperative survival and (2) rate of postoperative complica-
tions. Analysis of the the data set for primary outcomes was
based on non-parametrics tests; for number of complications,
the Mann-Whitney test was used, whereas for survival, the
log-rank test was used and for the difference in percentage
GTR between groups, a two-tailed t test. No adjustment for
multiple testing has been done. The significance level was
set to 5%. Forest plots were made with SPSS (Version
24.0; IBM Analytics). Analysis of the relationships be-




The search strategy yielded 3785 publications, of which 2026
remained after duplicates were removed. Twenty-three addi-
tional recoreds were identified through alternative search strat-
egies, mainly by searching the reference lists of the studies,
increasing the total number of records identified to 2049.
Following screening by title and abstract, 146 articles were
considered relevant and were assessed for eligibility. Review
of these 146 articles led to the inclusion of 53 studies in the
analysis, including 9102 patients. A total of 1260 patients
were operated using ISM; 7842 patients were operated under
general anesthesia. The study characteristics of the 53 publi-
cations are listed in the Data Supplement. Not all studies
allowed extraction of all end points. The complications
mainly consisted of motor and language deficits (Data
Supplement). The cohorts varied between 9 and 1229 pa-
tients. Included articles were publicated between 1999 and
2016. Twenty-two articles were of European origin, 21
articles were of North-American origin, eight articles were
of Asian origin, two articles were of South-American or-
igin, and one article was of Middle-East origin. Forty-
eight studies were performed in a university setting
(91%). Eleven studies used electrostimulation (sub) corti-
cal mapping intraoperatively. Eleven studies used evoked
potentials (such as MEPs, SEPs) intraoperatively. Four
studies used awake craniotomy as anesthetic modality.
The mean age of the study populations differed between
49.0 and 78.0 years. Percentage of eloquently located gli-
omas differed between 0 and 100%. The percentage of
patients in whom GTR was obtained differed between 6
and 96%. The overall postoperative median survival of
patients following diagnosis differed between 4.5 and
Total records identified through database searching (n=3785)
Embase (1399) Medline (OvidSP) (n=1172) Web of Science (n=924)
Google Scholar (n=208) Pubmed Publisher (n=53) Cochrane Library (n=29)
Records after duplicates removed (n=2026)
Records screened by title and abstract (n=2049)
Additional records identified through other searching (n=23)
Records excluded (n=1903)
Not relevant (n=1903)
Full-text articles assessed for eligiblity (n=146)
Articles excluded (n=93)
Mixed glioma grades (n=44)
Review (n=19)
Only LGG (n=16)
Histology not specified (n=4)
Pediatric glioma (n=3)
Editiorial, commentary or short report (n=3)
Chapter in book (n=2)
No abstract available (n=2)
Studies included in qualitative synthesis (n=53)




16.3 months. Postoperative complication rates differed be-
tween 0.0 and 0.64.
Overall survival
The median overall survival rates for each study are pro-
vided in Table 1 of the Data Supplement. Studies evalu-
ating craniotomy under GA with data on overall survival
(n = 17) included 4390 patients with a median overall sur-
vival of 12.04 months (SE = 1.14; 95% CI 9.80–14.28).
Studies evaluating craniotomy with ISM with available
data (n = 5) included 279 patients with a median overall
survival of 15.53 months (SE = 1.68; 95% CI 12.24–
18.82). Studies evaluating awake craniotomy (subgroep
of ISM) with available data (n = 3) included 210 patients
with a median overall survival of 16.87 months (SE =
0.75; 95% CI 15.40–18.34). The median survival in the
ISM group was almost 3.5 months longer than in the GA
group, but this was not significant (p = 0.085). The medi-
an survival in the awake group was more than 4.5 months
longer than in the GA group, which was significant
(p < 0.001). Forest plots for median overall survival rates
are displayed in Fig. 2.
Extent of resection and survival
Eighteen studies evaluated the extent of resection (expressed
as percentage of craniotomies in which gross total resection
(GTR) was achieved) in correlation with overall survival.
Percentages of craniotomies in which GTR was achieved in
each study are provided in Table 1 of the Data Supplement.
Using a mixed effects regression with unrestricted ML, a sig-
nificant positive relation was found between extent of resec-
tion and overall survival (b = 0.11; SE = 0.04; p = 0.012)
(Fig. 3), indicating extent of resection as a major prognostic
factor in high-grade glioma surgery.
Preoperative patient KPS and survival
Forty-five studies evaluated preoperative patient KPS
(Karnofsky Performance Score) in correlation with overall
survival. Preoperative patient KPS are provided in Table 1
of the Data Supplement. Using amixed effects regression with
unrestricted ML, a significant positive relation was found be-
tween preoperative patient KPS and overall survival (b = 0.61;
SE = 0.13; p < 0.001), indicating preoperative patient KPS as
a major prognostic factor in high-grade glioma surgery.
Postoperative complications
The postoperative complication rates for each study are pro-
vided in Table 1 of the Data Supplement. Studies evaluating
craniotomy under GA with data on postoperative
complications (n = 19) included 5826 patients with a total of
1250 postoperative complications. In this group, the postop-
erative complication rate was 0.21 (95% CI 0.20–0.23).
Studies evaluating craniotomy with ISM with available data
(n = 9) included 430 patients with a total of 54 postoperative
complications. In this group, the postoperative complication
rate was 0.13 (95% CI 0.10–0.16). The complication rate in
the ISM group was significantly lower than in the GA group
(p < 0.001).
Extent of resection
The extent of resection is expressed as percentage of GTR
obtained for each study. The data are provided in Table 1 of
the Data Supplement. Studies evaluating craniotomy under
GA with data on extent of resection (n = 24) included 6880
patients. In 3283 cases, GTR was obtained. In this group, the
mean percentage of GTR was 47.7% (95% CI 40.4–55.5).
Studies evaluating craniotomy with ISM with available data
(n = 6) included 369 patients. In 292 cases, GTR was obtain-
ed. In this group, the mean percentage of GTR was 79.1%
(95% CI 69.8–88.4). The mean percentage of GTR in the
ISM group was significantly higher than in the GA group
(p < 0.001).
Extent of resection and postoperative complications
Fifteen studies evaluated extent of resection (expressed as
percentage of craniotomies in which gross total resection
(GTR) was achieved) in correlation with postoperative com-
plications. Percentages of craniotomies in which GTR was
achieved in each study are provided in Table 1 of the Data
Supplement. Using a mixed effects regression with unrestrict-
ed ML, no relation was found between extent of resection and
overall survival (b = − 0.018; SE-0.012; p = 0.132) (Fig. 4),
indicating that achieving a higher extent of resection does
not yield a higher rate of postoperative complications.
Patient KPS and postoperative complications
Ten studies evaluated preoperative patient KPS in cor-
relation with postoperative complications. Percentages of
eloquent areas in each study are provided in Table 1 of
the Data Supplement. Using a mixed effects regression
with unrestricted ML, a significant positive relation was
found between patient KPS and postoperative complica-
tions (b = − 0.095; SE = 0.039; p = 0.014), indicating pre-
operative patient KPS as a major predictive factor for






First_author Statistics for each study Mean and 95% CI
Standard Lower Upper 
Mean error limit limit
Li 13,400 0,408 12,601 14,199
Ringel 25,000 1,247 22,556 27,444
Lacroix 15,900 0,687 14,554 17,246
Chaichana_2010 10,400 3,001 4,518 16,282
Oh 15,000 0,737 13,556 16,444
Chaichana_2014 10,050 3,887 2,432 17,668
Polin 10,000 0,914 8,208 11,792
Oszvald 13,100 0,839 11,456 14,744
Yamaguchi 21,100 1,063 19,016 23,184
Ewelt 6,700 0,958 4,823 8,577
Hoffermann 6,000 0,756 4,519 7,481
Konglund 8,300 0,703 6,921 9,679
Hassaneen 15,500 5,169 5,368 25,632
Kushnir 11,800 0,997 9,845 13,755
De Bonis 7,000 0,982 5,076 8,924
Kombos_2009b 11,300 0,693 9,942 12,658
Mandl 5,200 1,003 3,234 7,166
12,039 1,142 9,800 14,277
-30,00 -15,00 0,00 15,00 30,00
First_author Statistics for each study Mean and 95% CI
Standard Lower Upper 
Mean error limit limit
Talacchi 18,000 2,026 14,028 21,972
Yoshikawa 16,800 0,967 14,905 18,695
Signorelli 16,400 1,501 13,458 19,342
16,865 0,754 15,387 18,344
-30,00 -15,00 0,00 15,00 30,00
First_author Statistics for each study Mean and 95% CI
Standard Lower Upper 
Mean error limit limit
Talacchi 18,000 2,026 14,028 21,972
Ohue 16,300 2,139 12,108 20,492
Yoshikawa 16,800 0,967 14,905 18,695
Kombos_2009a 11,100 0,621 9,883 12,317
Signorelli 16,400 1,501 13,458 19,342
15,532 1,680 12,240 18,824
-30,00 -15,00 0,00 15,00 30,00
Fig. 2 Forest plot
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Eloquent areas and postoperative complications
Eleven studies evaluated the percentage of eloquent areas in
correlation with postoperative complications. Percentages of el-
oquent areas in each study are provided in Table 1 of the Data
Supplement. Using a mixed effects regression with unrestricted
ML, no overall relation was found between the percentage of
eloquent areas and postoperative complications (b = − 0.009;
SE = 0.013; p = 0.475). However, a significant relation was
found when evaluating only studies investigating craniotomies
under GA, indicating that a higher percentage of eloquent areas
was significantly positively related with a higher postoperative
complication rate (b = 0.044; SE = 0.007; p< 0.001).
Discussion
This meta-analysis shows that patients who had been operated
by surgeons using AC as ISM for a single supratentorial high-
grade glioma had a significant longer overall postoperative
median survival (more than 4.5 months longer) and were
subject of less postoperative complications in eloquent areas
(0.13 versus 0.21). Furthermore, the percentage of resections
in which GTR was obtained was significantly higher in the
ISM group as compared to the GA group (47.7% versus 79.1,
p < 0.001). The use of ISM and AC by surgeons is safe, as a
greater extent of resection did not yield a higher rate of com-
plications. Moreover, extent of resection and preoperative pa-
tient KPS were indicated as prognostic factors, whereas pa-
tient KPS and the involvement of eloquent areas were identi-
fied as predictive factors. These results suggest that the use of
ISM (AC in particular) by surgeons should be implemented as
a routine operation for surgery of high-grade tumors near el-
oquent areas of the brain.
It is important to recognize the ifs and buts of the use of
adjunct surgical techniques such as ISM and AC. The results
yielded by the use of such techniques are only as good as the
surgeon who uses these techniques. The fact that no technique
can ever replace knowledge, experience and skill should be
acknowledged, valued, and acted upon accordingly. Mapping
and monitoring during glioma resections are useless if the
surgeon is not familiar with using these techniques.
Fig. 3 Extent of resection and
overall survival
Fig. 4 Extent of resection and
postoperative complication rate
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Implementing new techniques takes practice and will inevita-
bly come with a certain learning curve regarding both techni-
cal use and case selection.
Neurosurgeons have a daunting task: resecting the tu-
mor with an extent as great as possible, while simulta-
neously minimizing the risk for postoperative complica-
tions and especially neurological morbidity. Surgeons use
ISM to maximize resection, primarily to increase the pa-
tient’s survival while minimizing the chances of morbidity
and loss of neurological function [2, 24]. AC is the most
frequently used form of ISM, by using electrocortical and
subcortical mapping to differ eloquent brain tissue from
brain or tumor tissue that is safe to resect. Hereby, surgeons
try to maximize the extent of resection with at the same
time minimizing the risk of postoperative complications.
To date, surgeons use ISM and AC in particular for the
resection of low-grade gliomas because of the usually
near-eloquent location of these tumors [4, 13]. Only few
studies have evaluated the use of these techniques in high-
grade gliomas, as is reflected in the studies included (see
also Table 1, Data Supplement). We showed that surgeons
using AC can significantly contribute to this goal by pre-
serving the quality of life of these patients and decreasing
the risk of postoperative morbidity when operating in elo-
quent areas, while increasing extent of resection and max-
imizing postoperative survival.
To the best of our knowledge, this is the first study that
systematically investigates the use of ISM and AC by sur-
geons in high-grade glioma surgery only.
A study and meta-analysis very similar to ours, con-
ducted by De Witt Hamer et al., included 8091 patients
with supratentorial infiltrative glioma (high- and low-
grade glioma) that were resected by surgeons using
ISM or not [7]. They found that glioma resections in
which the surgeon had used ISM were associated with
fewer late major neurologic deficits. These findings are
in accordance with our results evaluating high-grade gli-
oma resections, since we found that surgeons using AC
as ISM experienced decreased rates of postoperative
complications in eloquent areas.
Sacko et al. prospectively compared surgeons using AC
versus craniotomy under GA for resection of supratentorial
lesions including 575 glioma patients [19]. They found that
patients with tumors in eloquent areas revealed a significantly
better neurological outcome and extent of resection in the AC
group than the GA group. Although this study also includes
low-grade glioma patients, it is one of the largest prospective
studies comparing surgeons using AC and craniotomy under
GA head-to-head for postoperative outcomes in glioma sur-
gery. We found similar results after our data analysis, suggest-
ing a role for the use of AC by surgeons in resections for high-
grade glioma—especially in eloquent areas—to improve out-
comes after craniotomies.
Chaichana et al. conducted a retrospective study at the
Johns Hopkins University to develop a prognostic grading
system in glioblastoma patients [3]. They found that (among
others) a poor preoperative performance status proved to be a
strong prognostic factor in glioblastoma surgery. In accor-
dance with this findings, we found that preoperative patient
KPS was not only indicated as a prognostic factor, but also a
predictive factor (a poor preoperative KPS indicating an in-
creased risk of postoperative complications). These results
underline the importance of identifying subgroups of patients
within the high-grade glioma patient population and the role
ISM/AC use by surgeons can play in optimalization of surgery
outcomes.
This study should be interpreted whitin the limitations of a
meta-analysis based on observational studies. The selected
publications are observational or retrospective in nature and
therefore subject to selection bias, publication bias, and sub-
jective outcome assesments, as mentioned before by de Witt
et al. [7]. We therefore advise a randomized controlled trial
where awake craniotomy with ISM is compared to surgery
under general anesthesia for GBM near eloquent areas.
Primary outcomes should be focused on neurological morbid-
ity and extent of resection.
Publication bias can result in our findings being rather pre-
cise, with small 95% CIs, but less accurate as an estimation of
the ground truth of outcome in general neurosurgical practice,
since published data does not necessarily reflect general clin-
ical practice. For example, the overall low rate of mortality is
known to correlate with large-volume centers. We therefore
think our results may apply to high-grade glioma patients
treated in large-volume academic hospitals dedicated to
neuro-oncology. Secondly, the selection bias of our findings
can be expected due to patient selection with various indica-
tions for surgical intervention. However, we minimized the
risk for this bias by our vast amount of data and number of
included studies of patients.
Conclusions
Surgeons resecting high-grade glioma with ISM are able to
achieve a higher percentage of GTR, and the use of AC by
surgeons is associated with significantly longer overall post-
operative survival with less postoperative complications as
compared with craniotomy under GA. The greater extent of
resection achieved by mapping techniques did not yield a
higher rate of complications. Furthermore, extent of resection
and preoperative patient KPS were indicated as prognostic
factors, whereas patient KPS and the involvement of eloquent
areas were identified as predictive factors. Our findings con-
firm preliminary findings of other authors with smaller group
sizes and elaborate on large studies with both low-grade and
high-grade patient cohorts. Future studies should focus on
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evaluating the role of the use of AC by surgeons in the treat-
ment of high-grade glioma and optimize risk stratification
using prognostic factors. Subgroups of patients should be
identified that might benefit the most from extensive surgery
and AC. If future studies confirm and elaborate on the results
presented in this study, the role of awake craniotomies in
neurooncology should be revisited and expanded.
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Importance of the study
Aggressive surgery is warranted in glioblastoma surgery, since the extent of
resection improves survival in this patient group. However, since the
majority of glioblastomas are located in eloquent areas, operating
aggressively is often impossible due to imminent negative consequences
for survival and quality of life (QoL). Hence, a surgical technique
optimizing resection percentage of these tumors while preventing
neurological deficits is necessary. Implementation of the use of
intraoperative stimulation mapping (ISM) and awake craniotomy (AC) by
surgeons made this endeavor possible in eloquently located low-grade gli-
oma. Therefore, these techniques may be beneficial for surgeons resecting
glioblastoma in eloquent areas as well. The current literature regarding the
use of these techniques in glioblastoma surgery is insufficient. Our study
advances current research by summarizing the evidence for the use of these
techniques in glioblastoma surgery by investigating more than 9000 pa-
tients, hereby laying the foundation for further research regarding the
evidence-based use of these techniques in glioblastoma surgery.
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